octurnal protein supply during sleep as a dietary strategy to improve muscle mass in elderly
Completed
- Conditions
- spieropbouw bij ouderdommuscle losssarcopenia
- Registration Number
- NL-OMON34886
- Lead Sponsor
- niversiteit Maastricht
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 30
Inclusion Criteria
Male
65-80 yr of age
no medication
BMI < 30 kg/m2
Exclusion Criteria
Comorbidities associated with muscle metabolism
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>The primary endpoint will be muscle protein synthesis. Muscle protein synthesis<br /><br>will be calculated by differences in plasma and muscle tracer enrichments.<br /><br>Phenylalanine and tyrosine enrichment in plasma samples and in the muscle free<br /><br>amino acid pool will be measured using gas chromatography-mass spectrometry,<br /><br>while the phenylalanine enrichment in muscle proteins will be measured with<br /><br>GC-combustion IRMS. We measure muscle protein synthesis after nocturnal protein<br /><br>ingestion by nasogastric tube. </p><br>
- Secondary Outcome Measures
Name Time Method <p>None.</p><br>
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie nocturnal protein supply's impact on sarcopenia in elderly patients?
How does nocturnal protein supplementation compare to standard dietary interventions for muscle mass preservation in aging populations?
Are there specific biomarkers that predict response to nocturnal protein supply in sarcopenia management?
What adverse events are associated with nocturnal protein intake in elderly individuals and how can they be managed?
What are the potential synergistic effects of combining nocturnal protein supply with resistance training in sarcopenia treatment?